Atlas FDA

CLARION MULTI-STRATEGY COCHLEAR IMPLANT

FDA premarket approval P960058 · decided 1997-06-26

Approval details

PMA number
P960058
Trade name
CLARION MULTI-STRATEGY COCHLEAR IMPLANT
Generic name
Implant, cochlear
Applicant
Advanced Bionics
Date received
1996-12-30
Decision date
1997-06-26
Days to decision
178 days
Decision code
APPR
Product code
MCM
Advisory committee
Ear, Nose, Throat
Expedited review
No
Location
Valencia, CA
Statement
APPROVAL FOR THE CLARION MULTI-STRATEGY COCHLEAR IMPLANT. THE DEVICE IS INTENDED TO RESTORE A LEVEL OF AUDITORY SENSATION TO CHILDREN WITH PROFOUND SENSORINEURAL DEAFNESS VIA ELECTRICAL STIMULATION OF THE AUDITORY NERVE. CLARION IS INDICATED FOR THE FOLLOWING: 1)CHILDREN, 2 THROUGH 17 YEARS OF AGE. IF X-RAYS DEMONSTRATE EVIDENCE OF OSSIFICATION, CHILDREN AS YOUNG AS 18 MONTHS MAY BE IMPLANTED; 2)PROFOUND, BILATERAL SENSORINEURAL DEAFNESS; 3)UNDERGONE OR BE WILLING TO UNDERGO A HEARING AID TRAIL

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.